跳至主要内容
临床试验/NCT01396889
NCT01396889已完成不适用

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years in Bandarabbas Children' Hospital

Hormozgan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
occurrence of upper respiratory tract infection diagnosed by physician according to history and physical examination and laboratory tests if was necessary

研究概览

简要总结

Acute upper respiratory tract infections are the most commmon infections in children and are associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea is widely used for treatment of upper respiratoty tract infections. The aim of this study is to evaluate its efficacy as prophilaxis in children 1-5 years old.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Childrens 1-5 years old

排除标准

  • Wheezing in previous 3 months requiring bronchodilatator
  • History of hyperactive reactive airway
  • using steroid or Echinacea
  • chronic pulmonary of cardiac disease
  • Acute respiratory disease within one week before study
  • Allergic rhinitis
  • Allergy to Echinacea
  • avoiding to participate in the study

研究组 & 干预措施

Echinacea

Experimental

0.5ml daily for children 1-2 years old and 2ml daily for children2-5 years old for 3 months

干预措施: Echinacea (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

occurrence of upper respiratory tract infection diagnosed by physician according to history and physical examination and laboratory tests if was necessary

时间窗: 6 months

次要结局

  • Drug side effects(6 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验